Literature DB >> 9817563

Exploring the hidden danger of noncardiac drugs.

S G Priori.   

Abstract

Mesh:

Year:  1998        PMID: 9817563     DOI: 10.1111/j.1540-8167.1998.tb00889.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


× No keyword cloud information.
  10 in total

Review 1.  The significance of QT interval in drug development.

Authors:  Rashmi R Shah
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

Review 2.  Drugs, QT interval prolongation and ICH E14: the need to get it right.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 3.  Drugs, QTc interval prolongation and final ICH E14 guideline : an important milestone with challenges ahead.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 4.  Dealing with global safety issues : was the response to QT-liability of non-cardiac drugs well coordinated?

Authors:  Norman Stockbridge; Joel Morganroth; Rashmi R Shah; Christine Garnett
Journal:  Drug Saf       Date:  2013-03       Impact factor: 5.606

Review 5.  Pharmacogenetic issues in thorough QT trials.

Authors:  Richard S Judson; Benjamin A Salisbury; Carol R Reed; Michael J Ackerman
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

Review 6.  Genetic polymorphisms, drugs, and proarrhythmia.

Authors:  Dan M Roden
Journal:  J Interv Card Electrophysiol       Date:  2003-10       Impact factor: 1.900

Review 7.  Cardiac repolarisation and drug regulation: assessing cardiac safety 10 years after the CPMP guidance.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 8.  Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

9.  Sildenafil (Viagra) reduces arrhythmia severity during ischaemia 24 h after oral administration in dogs.

Authors:  Orsolya Nagy; Agnes Hajnal; James R Parratt; Agnes Végh
Journal:  Br J Pharmacol       Date:  2004-01-26       Impact factor: 8.739

10.  Effect of domperidone on the QTc interval in premature infants.

Authors:  A Günlemez; A Babaoğlu; A E Arisoy; G Türker; A S Gökalp
Journal:  J Perinatol       Date:  2009-07-23       Impact factor: 2.521

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.